Literature DB >> 32841950

Prognostic Significance of Red Cell Distribution Width in Idiopathic Pulmonary Fibrosis and Combined Pulmonary Fibrosis Emphysema.

Aslıhan Gürün Kaya1, Berna Akıncı Özyürek2, Tuğçe Şahin Özdemirel2, Miraç Öz3, Yurdanur Erdoğan2.   

Abstract

OBJECTIVE: The red cell distribution width (RDW) is an inexpensive, readily available prognostic indicator of several diseases. RDW has been assessed as a prognostic biomarker in patients with idiopathic pulmonary fibrosis (IPF) in only one study; furthermore, the relationship between the RDW and combined pulmonary fibrosis emphysema (CPFE) has yet to be reported. SUBJECTS AND METHODS: This single-center study was conducted between January 2015 and December 2018 in the Atatürk Chest Diseases and Chest Surgery Education and Research Hospital. Baseline characteristics, laboratory results, and survival status of patients were recorded.
RESULTS: The RDW value was significantly higher in the CPFE group than in the IPF group (median [IQR 25-75]; 16.8 [15.5-19] vs. 15.3 [13.7-16.8], p = 0.028). High RDW values were correlated with carbon monoxide diffusion capacity (DLCO) (r: -0.653 p = 0.001), 6-minute walking test (6MWT) distance (r: -0.361 p = 0.017), arterial partial oxygen pressure (PaO2) (r: -0.692 p < 0.001), and systolic pulmonary arterial pressure (SPAP) (r: 0.349 p = 0.022) in patients with fibrotic lung disease. The RDW value was significantly higher in the exitus group than in the survivors (median [IQR 25-75]; 18.4 [15.4-19] vs. 15.2 [13.5-17.2], p = 0.016). A univariate Cox regression analysis identified DLCO, SPAP, PaO2, and RDW as potential covariates of mortality. In a multivariate analysis, the DLCO (HR 1.21, 95% CI 1.11-1.47, p = 0.012) and RDW level (HR 1.65, 95% CI 1.09-2.47, p = 0.023) remained independent predictors of mortality.
CONCLUSION: High RDW values appear to be a simple prognostic factor in patients with IPF or CPFE.
© 2020 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Combined pulmonary fibrosis emphysema; Idiopathic pulmonary fibrosis; Red cell distribution width

Year:  2020        PMID: 32841950      PMCID: PMC8114038          DOI: 10.1159/000511106

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  29 in total

1.  The role of red blood cell distribution width in mortality and cardiovascular risk among patients with coronary artery diseases: a systematic review and meta-analysis.

Authors:  Chang Su; Li-Zhen Liao; Yan Song; Zhi-Wei Xu; Wei-Yi Mei
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 2.  Staging systems and disease severity assessment in interstitial lung diseases.

Authors:  Sara Tomassetti; J H Ryu; V Poletti
Journal:  Curr Opin Pulm Med       Date:  2015-09       Impact factor: 3.155

3.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

4.  Red cell distribution width in predicting 30-day mortality in patients with pulmonary embolism.

Authors:  Xiao-Yu Zhou; Hong-Lin Chen; Song-Shi Ni
Journal:  J Crit Care       Date:  2016-10-06       Impact factor: 3.425

5.  Persistent increase in red cell size distribution width after acute diseases: A biomarker of hypoxemia?

Authors:  Joseph W Yčas; Jay C Horrow; Benjamin D Horne
Journal:  Clin Chim Acta       Date:  2015-06-18       Impact factor: 3.786

Review 6.  New perspectives on management of idiopathic pulmonary fibrosis.

Authors:  Silvia Puglisi; Sebastiano Emanuele Torrisi; Virginia Vindigni; Riccardo Giuliano; Stefano Palmucci; Massimiliano Mulè; Carlo Vancheri
Journal:  Ther Adv Chronic Dis       Date:  2016-02-01       Impact factor: 5.091

7.  Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease.

Authors:  Yalcin Solak; Mahmut I Yilmaz; Mutlu Saglam; Kayser Caglar; Samet Verim; Hilmi U Unal; Mahmut Gok; Erkan Demirkaya; Abduzhappar Gaipov; Mehmet Kayrak; Hakki Cetinkaya; Tayfun Eyileten; Suleyman Turk; Abdulgaffar Vural
Journal:  Am J Med Sci       Date:  2014-02       Impact factor: 2.378

8.  Red blood cell distribution width and mortality risk in a community-based prospective cohort.

Authors:  Todd S Perlstein; Jennifer Weuve; Marc A Pfeffer; Joshua A Beckman
Journal:  Arch Intern Med       Date:  2009-03-23

Review 9.  Novel biomarkers for pulmonary arterial hypertension.

Authors:  Anjum Anwar; Gregoire Ruffenach; Aman Mahajan; Mansoureh Eghbali; Soban Umar
Journal:  Respir Res       Date:  2016-07-20

10.  Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension.

Authors:  Christopher J Rhodes; John Wharton; Luke S Howard; J Simon R Gibbs; Martin R Wilkins
Journal:  Heart       Date:  2011-05-10       Impact factor: 5.994

View more
  1 in total

1.  Red cell distribution width as a predictor for bronchopulmonary dysplasia in premature infants.

Authors:  Hayato Go; Hitoshi Ohto; Kenneth E Nollet; Kenichi Sato; Hirotaka Ichikawa; Yohei Kume; Yuji Kanai; Hajime Maeda; Nozomi Kashiwabara; Kei Ogasawara; Maki Sato; Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Sci Rep       Date:  2021-03-31       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.